AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Veprate-ER 750 Tablet

Prescription Icon
Prescription Required

Marketer

Ryon Pharma

Salt Composition

Divalproex (750mg)

Overview Veprate-ER 750 Tablet

Extended-release Verapamil 750 mg tablets are prescribed for epilepsy management, preventing and controlling seizures. This medication also aids in migraine prophylaxis and may be employed in bipolar disorder treatment. Dosage and frequency are determined individually by your physician to optimize symptom control; it can be taken with or without food, but consistent daily timing is crucial for maximum effectiveness. Therapeutic effects typically manifest within a couple of weeks. Continuous use as directed is vital; missed doses risk seizure recurrence, and abrupt cessation can worsen your condition. Gradual discontinuation is essential. Common side effects include headache, blurred vision, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. While most are mild, persistent or bothersome effects warrant medical consultation. Report skin rashes or redness immediately. Prolonged use may contribute to osteoporosis and increased fracture risk. Rarely, suicidal ideation or behavior may occur; report any depressive mood changes to your doctor. This medication may not be appropriate for all patients. Inform your physician of any pre-existing heart conditions, kidney or liver impairment, urinary difficulties, depression, or suicidal tendencies before commencing treatment. Potential drug interactions exist; disclose all current medications to ensure safe use. Pregnant individuals should consult their doctor before starting or stopping this medication. Alcohol consumption should be avoided due to increased side effect risk and heightened seizure potential. Regular blood tests, both pre- and post-treatment initiation, help monitor optimal dosage.

Uses of Veprate-ER 750 Tablet

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prevention

Major Benefits of Veprate-ER 750 Tablet:

Follow your doctor's instructions or consult the product label for proper administration. Veprate-ER 750 Tablets can be ingested with or without food, however, consistent daily timing is recommended.

Common Side effects of Veprate-ER 750 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Veprate-ER 750 Tablet:

Follow your physician's instructions or consult the product label for proper administration. The 750mg Veprate-ER tablet can be ingested with or without food; however, consistent daily timing is recommended.

How Veprate-ER 750 Tablet works:

Extended-release Veprate 750 mg tablets are used to manage epilepsy. Their mechanism involves reducing the hyperactivity of neurons in the brain, thus controlling seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Veprate-ER 750 Tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Veprate 750 mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release vapreotide 750 mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of Veprate-ER 750 Tablets.

KidneyKidneySAFE IF PRESCRIBED

Veprate-ER 750 Tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverUNSAFE

The use of Veprate-ER 750 tablets is likely inadvisable for individuals with hepatic impairment and should be forgone. Medical advice is recommended.

What if you forget to take Veprate-ER 750 Tablet :

Should you forget a Veprate-ER 750 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Veprate-ER 750 Tablet

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Actions Antiepileptic drugs targeting sodium channels

FAQs on Veprate-ER 750 Tablet

Always consult your doctor before discontinuing Veprate-ER 750 Tablet. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors. Abrupt cessation may be harmful.
Yes, Veprate-ER 750 Tablets are sometimes used to stabilize mood, particularly in individuals experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these mood fluctuations.
Yes, Veprate-ER 750 Tablets can cause weight gain, potentially due to increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor if weight gain is a concern.
Drowsiness is a possible side effect of Veprate-ER 750 Tablets. Refrain from driving or operating machinery until you understand its impact on your alertness.
Hair loss is a possible side effect of Veprate-ER 750 Tablets, typically temporary and related to dosage. Consult your doctor if this side effect concerns you or continues.
Veprate-ER 750 Tablets can cause liver damage, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver injury. Baseline liver function tests are recommended before initiating therapy, with regular monitoring during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from drinking alcohol during your Veprate-ER 750 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Veprate-ER 750 Tablet treatment, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to minimize the risk of bleeding or bruising. Liver function tests are also recommended before and periodically (especially during the first six months) for patients at higher risk or with a history of liver disease.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Veprate-ER 750 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Veprate-ER 750 Tablet
101
MRP 123
17% off